Edris Badreddin bought EWTX
June 5, 2026 · Form 4 insider transaction
Edris Badreddin bought 5,619 shares of Edgewise Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 11 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,619
Price
$0.00
Total value
N/A
InsiderEdris Badreddin
RoleDirector
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJune 5, 2026
Filing dateJune 16, 2026
Shares owned after5,619
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
100% of the Restricted Stock Units granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder.